TCRT

Alaunos Therapeutics Inc

TCRT, USA

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

https://www.alaunos.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TCRT
stock
TCRT

Hedge Fund Moves: What is the fair value of TCRT stock now - 2025 Historical Comparison & Fast Exit/Entry Strategy Plans moha.gov.vn

Read more →
TCRT
stock
TCRT

Alaunos Therapeutics, Inc. (TCRT) Drops 6% in Pre-market: Trading Without a Clear Catalyst Stocks Telegraph

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$1.75

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.32

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-41.35 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-31.12 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.33

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 5.06% of the total shares of Alaunos Therapeutics Inc

1.

BlackRock Inc

(0.9681%)

since

2025/06/30

2.

Vanguard Group Inc

(0.9508%)

since

2025/06/30

3.

Geode Capital Management, LLC

(0.7229%)

since

2025/06/30

4.

Vanguard Institutional Extnd Mkt Idx Tr

(0.6376%)

since

2025/07/31

5.

Fidelity Extended Market Index

(0.4145%)

since

2025/07/31

6.

UBS Group AG

(0.309%)

since

2025/06/30

7.

Extended Equity Market Fund K

(0.1312%)

since

2025/06/30

8.

Fidelity Series Total Market Index

(0.1121%)

since

2025/07/31

9.

Fidelity Total Market Index

(0.1077%)

since

2025/07/31

10.

Morgan Stanley - Brokerage Accounts

(0.0815%)

since

2025/06/30

11.

Northern Trust Extended Eq Market Idx

(0.0615%)

since

2025/06/30

12.

NT Ext Equity Mkt Idx Fd - L

(0.0615%)

since

2025/06/30

13.

Fidelity Nasdaq Composite Index

(0.0506%)

since

2025/07/31

14.

Steward Partners Investment Advisory, LLC

(0.0498%)

since

2025/06/30

15.

NT Ext Equity Mkt Idx Fd - NL

(0.0492%)

since

2025/06/30

16.

Tower Research Capital LLC

(0.0441%)

since

2025/06/30

17.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0382%)

since

2025/06/30

18.

Spartan Total Market Index Pool G

(0.0347%)

since

2025/07/31

19.

State St US Extended Mkt Indx NL Cl C

(0.0337%)

since

2025/08/31

20.

Advisor Group Holdings, Inc.

(0.0315%)

since

2025/06/30

21.

Vanguard U.S. Eq Idx £ Acc

(0.0227%)

since

2025/07/31

22.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0174%)

since

2025/06/30

23.

Extended Equity Market Fund M

(0.0165%)

since

2025/06/30

24.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0146%)

since

2024/12/31

25.

SSgA U.S. Total Market Index Strategy

(0.0141%)

since

2025/03/31

26.

Atlantic Trust Group, LLC

(0.0136%)

since

2025/06/30

27.

Group One Trading, LP

(0.0136%)

since

2025/06/30

28.

Wells Fargo & Co

(0.0083%)

since

2025/06/30

29.

State St US Ttl Mkt Indx NL Cl A

(0.0074%)

since

2025/08/31

30.

Northern Trust Wilshire 5000

(0.0063%)

since

2025/06/30

31.

NT Quality Small Cap Core

(0.0058%)

since

2025/06/30

32.

Barclays PLC

(0.0045%)

since

2025/06/30

33.

Royal Bank of Canada

(0.0045%)

since

2025/03/31

35.

Bank of America Corp

(0.0039%)

since

2025/06/30

36.

Bank of Oklahoma National Association

(0.003%)

since

2025/06/30

37.

Asset Dedication, LLC

(0.0021%)

since

2025/06/30

38.

KEY Financial, INC.

(0.0011%)

since

2025/06/30

39.

Newbridge Financial Services Group, Inc.

(0.0011%)

since

2025/06/30

40.

SignatureFD, LLC

(0.001%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-06-30

EPS Actual

-0.63

EPS Estimate

—

EPS Difference

0

Surprise Percent

null%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(0.5)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Fair Value(6)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.